Vice President, Integrated Communications
Sharon rejoined LaVoieHealthScience (LHS) in 2016 bringing more than 20 years of life science marketing and corporate communications management experience at both public and private companies. Throughout her career, Sharon has worked on integrated corporate communications strategies for investor, media and professional advocacy relations; and she has led the communications process for multiple NDA approvals, product launches, as well as several sNDAs and IPOs.
Prior to joining LHS, Sharon was Senior Director of Corporate Communications at Navidea Biopharmaceuticals, a biotech focused on development and commercialization of immunodiagnostics and therapeutics to identify and treat diseases, Sharon was a key strategic partner in developing and managing external and internal communications to effectively influence key investor, stakeholder, medical and media perception of Navidea and drive engagement.
Previously, Sharon held communication management roles with BioScale, Inc. (now Proterix Bio), Alseres Pharmaceuticals, Aderis Pharmaceuticals, Oscient, Caliper Life Sciences and Millipore.
Sharon worked at LHS, holding increasing roles of responsibility between 2009 and 2013.
Sample Client Representation (past and present)
BioScale, Inc. (now ProterixBio)
Pfizer Animal Health
Integrated corporate marketing & communications strategies
Investor, public and professional advocacy relations
Corporate naming and positioning
Technical & scientific communications
Tradeshow, conference & event planning
Website and corporate collateral development
Bachelor of Science in Biochemistry, Minor in Chemistry, Pennsylvania State University
Graduate courses in Management and Finance, American University and NVCC
Skiing, painting, singing, decorating and sports
National Investor Relations Institute New England Women in Science Executives Public Relations Society of America Mass Bio Communications Group
Phone: 617-374-8800 x105